US AAA–AA Senior Unsecured Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-09-10
https://bondscovery.com/yield-curve/usd-corporate-senior-unsecured-aaa-aa-healthcare-pharmaceuticals
US AAA–AA Senior Unsecured Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-09-10: 10Y at 5.46%, fitted curve 3M–40Y (4.48%–6.15%), 195 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 3M | 4.48% | — |
| 6M | 4.51% | 4.65% |
| 9M | 4.54% | 4.69% |
| 12M | 4.57% | 4.69% |
| 18M | 4.64% | 4.82% |
| 2Y | 4.70% | 4.96% |
| 3Y | 4.84% | 5.21% |
| 4Y | 4.98% | 5.50% |
| 5Y | 5.08% | 5.62% |
| 6Y | 5.15% | 5.66% |
| 7Y | 5.22% | 5.84% |
| 8Y | 5.30% | 6.11% |
| 9Y | 5.39% | 6.33% |
| 10Y | 5.46% | 6.49% |
| 15Y | 5.75% | 6.80% |
| 20Y | 5.92% | 7.02% |
| 25Y | 6.01% | 6.98% |
| 30Y | 6.06% | 6.84% |
| 40Y | 6.15% | 7.59% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.70% and the 10-year 5.46%, a 10Y−2Y spread of +76 bp — positively sloped — as of 2026-09-10. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-09-10 | 1m ago2026-08-11 | 2m ago2026-07-13 | 3m ago2026-06-12 | 4m ago2026-05-13 | 5m ago2026-04-13 | 6m ago2026-03-13 |
|---|---|---|---|---|---|---|---|
| 2Y | 4.70% | 4.46% | 4.43% | 4.32% | 4.18% | 4.07% | 3.85% |
| 10Y | 5.46% | 5.30% | 5.15% | 5.09% | 4.97% | 4.83% | 4.82% |
| 10Y − 2Y | +76 bp | +83 bp | +72 bp | +76 bp | +79 bp | +76 bp | +96 bp |
Bonds in this curve
A selection of 30 of the 197 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Roche Holding AG | 4.50% | 2026-11-13 | 5.26% | US771196CE02 |
| Abbott Laboratories | 4.29% | 2026-11-30 | 3.75% | US002824BF69 |
| Roche Holding AG | 4.87% | 2027-01-28 | 2.38% | USU75000BL90 |
| Novartis | 4.34% | 2027-02-14 | 2.00% | US66989HAQ11 |
| ELI Lilly & CO | 4.41% | 2027-05-15 | 3.10% | US532457BP26 |
| Novartis | 4.79% | 2027-05-17 | 3.10% | US66989HAN89 |
| Johnson & Johnson | 4.31% | 2027-09-01 | 0.95% | US478160CP78 |
| Merck & CO INC | 4.52% | 2027-09-15 | 3.85% | US58933YBP97 |
| Johnson & Johnson | 4.47% | 2028-01-15 | 2.90% | US478160CK81 |
| Abbott Laboratories | 4.61% | 2028-01-30 | 1.15% | US002824BP42 |
| Sanofi SA | 4.76% | 2028-06-19 | 3.62% | US801060AD60 |
| Roche Holding AG | 4.78% | 2028-09-17 | 3.62% | USU75000BP05 |
| ELI Lilly & CO | 4.94% | 2029-03-15 | 3.38% | US532457BV93 |
| Merck & CO INC | 4.75% | 2029-03-15 | 3.85% | US58933YBW49 |
| Merck & CO INC | 5.00% | 2030-05-17 | 4.30% | US58933YBJ38 |
| Merck & CO INC | 4.98% | 2030-06-24 | 1.45% | US58933YAZ88 |
| Abbott Laboratories | 5.05% | 2031-03-15 | 4.00% | US002824BS80 |
| ELI Lilly & CO | 5.02% | 2031-03-15 | 4.25% | US532457DC94 |
| Merck & CO INC | 5.17% | 2032-09-15 | 4.55% | US58933YBR53 |
| ELI Lilly & CO | 5.20% | 2032-10-15 | 4.55% | US532457DD77 |
| Abbott Laboratories | 5.25% | 2033-03-15 | 4.30% | US002824BT63 |
| Novartis | 5.20% | 2033-03-18 | 4.60% | US66989HBH03 |
| Johnson & Johnson | 5.07% | 2034-06-01 | 4.95% | US478160CW20 |
| Merck & CO INC | 5.52% | 2035-09-15 | 4.95% | US58933YBS37 |
| Abbott Laboratories | 5.48% | 2036-03-15 | 4.65% | US002824BU37 |
| Abbott Laboratories | 5.63% | 2039-04-01 | 6.00% | US002824AV29 |
| Novartis | 5.90% | 2044-05-06 | 4.40% | US66989HAH12 |
| ELI Lilly & CO | 6.01% | 2049-03-15 | 3.95% | US532457BT48 |
| Johnson & Johnson | 5.72% | 2054-06-01 | 5.25% | US478160CX03 |
| Merck & CO INC | 6.13% | 2061-12-10 | 2.90% | US58933YBG98 |